95%+ ACCURACY, OFFICIALLY CERTIFIED: Apex AI Validated by South Korea’s Government-Designated KTC
The official English-translated certification from KTC (South Korea’s national testing authority) is now available, confirming Apex AI’s benchmark performance in early GI-cancer detection.
Here are the test results:
Colon Cancer Risk Detection (n = 868)
- Precision: 98.4%
- Recall: 98.7%
- Specificity: 99.6%
- Accuracy: 99.4%
- F1 Score: 98.6%
Upper GI Cancer Risk Detection (n = 1,847)
- Precision: 95.1%
- Recall: 94.6%
- Specificity: 99.6%
- Accuracy: 95.5%
- F1 Score: 94.8%
Lower GI Cancer Risk Detection (n = 211)
- Precision: 98.4%
- Recall: 99.3%
- Specificity: 99.3%
- Accuracy: 99.1%
- F1 Score: 98.8%
Validation covered 2,926 endoscopic images across upper, lower and colonic regions, meeting or exceeding every KTC threshold; an early, government-certified proof-point we’ll now build upon with larger, prospective trials.
Show original7.77K
99
The content on this page is provided by third parties. Unless otherwise stated, OKX is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.